Blog - Page 1872 of 5721

WednesdayNov 13, 2019 3:16 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Advances Development of Proprietary Drug-Delivery Platform

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, continues to progress the development and patenting of its DehydraTECH(TM) platform. An article discussing the company reads, “The DehydraTECH(TM) drug-delivery platform can be used to deliver substances in edible or in beverage form, and in capsules, pills, syrups and more. Brands in both Canada and the United States have licensed DehydraTECH to make their CBD and cannabis beverages best-in-class. . . . Not only is ingestion a much safer form of drug delivery, but DehydraTECH also delivers the active ingredient of the substance at a rate that is…

WednesdayNov 13, 2019 2:19 pm

Fintech Holding Company Xalles Holdings Inc. (XALL) Answers Crypto Business Needs as Coin Markets Gather New Strength

Xalles Holdings is a company dedicated to building on blockchain and other technologies for solutions in the e-commerce, payments and financial reconciliation arenas Xalles’ most recent financials report showed the company’s fifth consecutive revenue-producing quarter and expectations for future revenue and asset growth The company remains bullish on cryptocurrencies such as bitcoin amid the market’s ups and downs, with recent worldwide rising trends underscoring crypto’s and Xalles’ potential The potential benefits of riding out crypto volatility were again on display in late October as Bitcoin suddenly surged over $500 in just five minutes, joined in the ride by other top-20…

WednesdayNov 13, 2019 1:20 pm

Predictive Oncology Inc.’s (NASDAQ: POAI) AI-Driven Predictive Models Better Inform Clinicians, Researchers; Changing Landscape of Cancer Treatment

POAI subsidiary Helomics announce sequencing of ovarian tumor cases from UPMC Magee collaboration, a critical step in strategic Cancer Quest 2020 initiative Data key to value in $48-billion precision-medicine industry Industry leaders such as POAI realize critical value in patient-specific, data-driven models The field of drug development for cancer treatment involves costly and time-intensive research. As technology plays an ever-increasing role in driving medicine, researchers and clinicians are discovering the significant potential of patient-derived models in matching specific cancer types with their most effective treatments. These models, which harness the patients’ own cancer cells to best determine how to defeat…

WednesdayNov 13, 2019 12:02 pm

QualityStocksNewsBreaks – SinglePoint Inc. (SING) Reports Record Q3 2019 Results, Expects Significant Growth in Solar and Hemp Businesses

Leading technology and acquisition company SinglePoint (OTCQB: SING) today announced its financial results for the third quarter ended September 30, 2019. According to the update, the company achieved revenues of $1,050,374 for the three months ended September 30, 2019, a 176% increase over the same period in 2018. Per the update, the initial response to the company’s Pure American Hemp Cigarette has been overwhelming, while Direct Solar, SinglePoint’s most recent acquisition, continues to exceed revenue targets and has been pivotal to the company’s financial growth. “This has been a great quarter for SinglePoint, we are very excited to see the…

WednesdayNov 13, 2019 11:47 am

Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) Sees Streaming Revolution as Opportunity to Produce Original Content

Wonderfilm Media is backed by four Hollywood producers with $1 billion worth of movie revenues between them Wonderfilm’s producing team is attending American Film Market to pre-sell intellectual properties for the company’s expanding slate of movies and television/streaming series and potentially solidify new projects With a $58 million total budget and 17 productions greenlit, Wonderfilm’s low-risk approach to content production results in predictable and consistent revenue streams Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF), a publicly traded entertainment company, with offices in Los Angeles and Vancouver, has developed a risk-averse production process that provides forecastable and consistent revenues. This innovative…

WednesdayNov 13, 2019 11:37 am

QualityStocksNewsBreaks – ChineseInvestors.com Inc.’s (CIIX) China Division Featured in WSJ Video on Opportunities to Cash In on US CBD Products Rush

ChineseInvestors.com’s (OTCQB: CIIX) China Division was featured in a video published by The Wall Street Journal today, which highlighted Chinese entrepreneurs and opportunities to cash in as products made with cannabidiol (“CBD”) take off in the U.S. The accompanying article, written by Stephanie Yang and Clément Bürge, highlighted the fact that, while marijuana is still seen as a dangerous narcotic in China, Chinese entrepreneurs “are navigating the highly-sensitive industry as they try to turn their country into a CBD superpower.” CIIX CEO Summer Sun, who leads the company’s Chinese branch, was featured in the video as he discussed the company’s…

WednesdayNov 13, 2019 11:20 am

MCTC Holdings Inc. (MCTC) is “One to Watch”

Achieving considerable progress in the research and development of new products utilizing its innovative cannabinoid delivery systems In the process of introducing several cannabinoid consumer products based on the company’s internally developed high bioavailability infusion technologies Highly experienced management team with significant participation in the cannabis and hemp industries IP portfolio includes four patents on the company’s cannabinoid delivery technology systems MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019…

WednesdayNov 13, 2019 10:17 am

QualityStocksNewsBreaks – VPR Brands LP (VPRB) Announces Q3 and Year-to-Date 2019 Results, Posting Increased Revenues for Both

VPR Brands (OTCQB: VPRB), a market leader specializing in vaporizers and accessories for essential oils, cannabis concentrates and extracts (“CBD”), as well as electronic cigarettes containing nicotine, today announced its financial results for the third quarter and year-to-date 2019, posting increased revenues for both as compared to 2018. As compared to the same periods last year, VPR Brands achieved a 13% increase in sales revenue to $1.4 million for the third quarter of 2019 and a 24% increase in sales revenue to $4.3 million for the nine months ended September 30, 2019. “We believe VPR Brands performed well in Q3…

WednesdayNov 13, 2019 9:23 am

QualityStocksNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) to Host Q1 Fiscal 2020 Earnings Conference Call

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) on Tuesday announced that it will release its first quarter fiscal 2020 results after market close on Monday, November 25, 2019. GGBXF will also be holding a conference call with company management to discuss the results at 8:30 AM ET on Tuesday, November 26, 2019. To join the call, dial (+1) 416 764 8609 for the local Toronto line, (+1) 778 383 7417 for the local Vancouver line, or (+1) 888 390 0605 for the North American toll-free line. The conference ID is 54236169. The call and replay will also…

Site Search

Company Search